$92.62
0.010.01%
Last update: Nov 10, 9:26 AM
LivaNova PLC
LIVNNASDAQ
LivaNova rose 82.0% from $50.88 to $92.61, ahead of the S&P 500's +10.5%. Its worst day was Aug 5 (−8.4%), and its low came Nov 10 at $50.88.
Story events cover the past 12 months · Times ET
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Provides 2030 Targets for Revenue and EPS GrowthLivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today hosted its 2025 Investor Day and presented its comprehensive strategic roadmap and long-range
+7.5% · S&P 500 +0.1%
LivaNova shares rose 9.4%, while the S&P 500 rose 1.5%.
+9.4% · S&P 500 +1.5%
EPS of $0.86 beat the $0.76 estimate on $360.9M revenue (est. $353.0M); FY revenue guidance of $1.4B–$1.4B against the $1.5B consensus.
+1.8% · S&P 500 +0.8%
EPS of $0.98 beat the $0.86 estimate on $362.3M revenue (est. $346.8M); FY revenue guidance of $1.4B–$1.5B against the $1.5B consensus.
+15.1% · S&P 500 +1.4%
EPS of $1.26 beat the $1.06 estimate on $390.6M revenue (est. $380.4M); FY revenue guidance of $1.5B–$1.5B against the $1.5B consensus.
−8.4%, the year's worst day · S&P 500 −0.2%
EPS of $1.23 beat the $1.03 estimate on $393.1M revenue (est. $380.9M); FY revenue guidance of $1.5B–$1.5B against the $1.5B consensus.
+17.9%, the year's best day, on 4M shares, the year's heaviest volume · S&P 500 +1.7%
Where it ended: a close of $92.61 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 24, 2027 (EPS est. $0.96, revenue est. $389.0M).
Nothing in the past 12 months.
All LIVN dividend history
